| 2019 FDA TIDES (peptides and oligonucleotides) harvest D Al Shaer, O Al Musaimi, F Albericio, BG de la Torre Pharmaceuticals 13 (3), 40, 2020 | 149* | 2020 |
| 2020 FDA TIDES (peptides and oligonucleotides) harvest O Al Musaimi, D Al Shaer, F Albericio, BG de la Torre Pharmaceuticals 14 (2), 145, 2021 | 83 | 2021 |
| Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens D Al Shaer, O Al Musaimi, BG de la Torre, F Albericio European Journal of Medicinal Chemistry 208, 112791, 2020 | 70 | 2020 |
| 2017 FDA peptide harvest O Al Musaimi, D Al Shaer, BG De la Torre, F Albericio Pharmaceuticals 11 (2), 42, 2018 | 56 | 2018 |
| Influence of age, gender, smoking, diabetes, thyroid and cardiac dysfunctions on cystatin C biomarker O Al Musaimi, AH Abu-Nawwas, D Al Shaer, NY Khaleel, M Fawzi Medicina de Familia. Semergen 45 (1), 44-51, 2019 | 21 | 2019 |
| The challenge of peptide nucleic acid synthesis KP Nandhini, D Al Shaer, F Albericio, BG de la Torre Chemical Society Reviews, 2023 | 8 | 2023 |
| Green circular economy applied to peptide synthesis O Al Musaimi, D Al Shaer, B De la Torre, F Albericio Teknoscienze, 2021 | 5 | 2021 |
| Solid-phase synthesis of peptides containing 1-Hydroxypyridine-2-one (1, 2-HOPO) D Al Shaer, F Albericio, BG de la Torre Tetrahedron Letters 61 (37), 152299, 2020 | 2 | 2020 |
| Protocol for efficient solid-phase synthesis of peptides containing 1-hydroxypyridine-2-one (1, 2-HOPO) D Al Shaer, BG de la Torre, F Albericio Methods X 7, 2020 | 2 | 2020 |
| New HPLC method for determination of cystatin C biomarker in human blood OI AlMusaimi, AAH Abu-Nawwas, DM AlShaer, NY Khaleel European Journal of Chemistry 8 (4), 378-383, 2017 | 2 | 2017 |
| Synthesis of New Peptide‐Based Ligands with 1, 2‐HOPO Pendant Chelators and Thermodynamic Evaluation of Their Iron (III) Complexes DM Al Shaer, F Albericio, BG de la Torre ChemistrySelect 6 (30), 7674-7681, 2021 | 1 | 2021 |
